Agenus Inc. (AGEN)
$7.67+1.72%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $319M
- Beta
- 1.55
- P/E (TTM)
- 2.76
- Short % float
- 18.33%
- Days to cover
- 5.7
- SI change
- +0.2%
- 1W
- -8.25%
- 1M
- +11.32%
- vs SPY 1W
- -9.41%
- vs SPY 1M
- +8.33%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AGEN?
- LOPJLB’s latest quantitative signal on Agenus Inc. (AGEN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AGEN in?
- Agenus Inc. (AGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Agenus Inc. (AGEN) do?
- Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies. Agenus is als…